Skip to main content
OpenTrials

Clinical trial condition

Lung Cancer, Non-small Cell

Explore clinical trials studying Lung Cancer, Non-small Cell. Study availability and eligibility vary by location and protocol.

44 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Lung Cancer, Non-small Cell trial results

Completed

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

NCT03847519

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Illinois CancerCare, P.C. Peoria, Illinois, United States
View Trial Details
Completed

Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

NCT00290355

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Edegem, Belgium
  • GSK Investigational Site Ghent, Belgium
  • GSK Investigational Site Leuven, Belgium
View all 62 locations
View Trial Details
Completed

A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor

NCT01853878

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Newark, Delaware, United States
  • GSK Investigational Site Springfield, Illinois, United States
  • GSK Investigational Site Rochester, Minnesota, United States
  • GSK Investigational Site Paterson, New Jersey, United States
View all 39 locations
View Trial Details
Completed

Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer

NCT00065182

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
View all 85 locations
View Trial Details
Completed

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

NCT00619424

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Buffalo, New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site Orbassano (TO), Piedmont, Italy
View Trial Details
Completed

A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase

NCT00528281

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Großhansdorf, Schleswig-Holstein, Germany
  • GSK Investigational Site Orbassano (TO), Piedmont, Italy
  • GSK Investigational Site Poznan, Poland
View Trial Details

Related conditions